Trinity Biotech PE Ratio 2010-2023 | TRIB
Current and historical p/e ratio for Trinity Biotech (TRIB) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Trinity Biotech PE ratio as of May 14, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Trinity Biotech PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-05-14 | 1.52 | 0.00 | |
| 2023-09-30 | 3.68 | $-3.75 | 0.00 |
| 2023-06-30 | 4.76 | $-4.05 | 0.00 |
| 2023-03-31 | 4.70 | $-4.70 | 0.00 |
| 2022-12-31 | 4.95 | $-6.45 | 0.00 |
| 2022-09-30 | 5.36 | $-5.45 | 0.00 |
| 2022-06-30 | 6.13 | $-3.80 | 0.00 |
| 2022-03-31 | 5.30 | $-2.55 | 0.00 |
| 2021-12-31 | 7.15 | $0.45 | 15.89 |
| 2021-09-30 | 10.80 | $-0.80 | 0.00 |
| 2021-06-30 | 14.70 | $0.35 | 42.00 |
| 2021-03-31 | 18.80 | $0.60 | 31.33 |
| 2020-12-31 | 19.05 | $-0.10 | 0.00 |
| 2020-09-30 | 10.10 | $-2.90 | 0.00 |
| 2020-06-30 | 10.90 | $-4.30 | 0.00 |
| 2020-03-31 | 5.50 | $-5.25 | 0.00 |
| 2019-12-31 | 5.17 | $-5.10 | 0.00 |
| 2019-09-30 | 6.05 | $-5.35 | 0.00 |
| 2019-06-30 | 8.25 | $-5.40 | 0.00 |
| 2019-03-31 | 14.25 | $-4.35 | 0.00 |
| 2018-12-31 | 11.45 | $-4.20 | 0.00 |
| 2018-09-30 | 20.00 | $-7.60 | 0.00 |
| 2018-06-30 | 25.00 | $-7.65 | 0.00 |
| 2018-03-31 | 25.75 | $-7.60 | 0.00 |
| 2017-12-31 | 25.50 | $-7.45 | 0.00 |
| 2017-09-30 | 28.05 | $-18.10 | 0.00 |
| 2017-06-30 | 30.00 | $-18.30 | 0.00 |
| 2017-03-31 | 29.80 | $-18.05 | 0.00 |
| 2016-12-31 | 34.60 | $-18.60 | 0.00 |
| 2016-09-30 | 66.10 | $0.55 | 120.18 |
| 2016-06-30 | 56.70 | $3.30 | 17.18 |
| 2016-03-31 | 58.30 | $3.35 | 17.40 |
| 2015-12-31 | 58.80 | $4.50 | 13.07 |
| 2015-09-30 | 57.20 | $4.90 | 11.67 |
| 2015-06-30 | 90.30 | $3.15 | 28.67 |
| 2015-03-31 | 95.08 | $3.55 | 26.78 |
| 2014-12-31 | 86.49 | $3.60 | 24.02 |
| 2014-09-30 | 90.24 | $3.65 | 24.72 |
| 2014-06-30 | 113.75 | $2.10 | 54.17 |
| 2014-03-31 | 118.58 | $2.05 | 57.85 |
| 2013-12-31 | 123.04 | $2.05 | 60.02 |
| 2013-09-30 | 106.50 | $2.10 | 50.71 |
| 2013-06-30 | 82.47 | $3.75 | 21.99 |
| 2013-03-31 | 81.67 | $3.85 | 21.21 |
| 2012-12-31 | 69.77 | $3.90 | 17.89 |
| 2012-09-30 | 60.81 | $3.80 | 16.00 |
| 2012-06-30 | 58.06 | $3.70 | 15.69 |
| 2012-03-31 | 50.95 | $3.60 | 14.15 |
| 2011-12-31 | 48.61 | $3.50 | 13.89 |
| 2011-09-30 | 43.74 | $3.45 | 12.68 |
| 2011-06-30 | 47.46 | $3.25 | 14.60 |
| 2011-03-31 | 44.34 | $14.40 | 3.08 |
| 2010-12-31 | 41.65 | $14.30 | 2.91 |
| 2010-09-30 | 29.92 | $14.20 | 2.11 |
| 2010-06-30 | 28.74 | $14.20 | 2.02 |
| 2010-03-31 | 25.76 | $2.90 | 8.88 |
| 2009-12-31 | 19.10 | $2.75 | 6.94 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.012B | $0.057B |
| Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. It also engages in the provision of engineering, financial, and management services, as well as in trading business. Trinity Biotech sells its products through its sales force, as well as through a network of distributors and strategic partners. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $180.939B | 23.69 |
| Stryker (SYK) | United States | $123.542B | 29.59 |
| Medtronic (MDT) | Ireland | $111.935B | 15.85 |
| Boston Scientific (BSX) | United States | $107.817B | 34.34 |
| EssilorLuxottica (ESLOY) | France | $101.153B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $41.922B | 0.00 |
| Haleon (HLN) | United Kingdom | $37.990B | 27.73 |
| ResMed (RMD) | United States | $31.710B | 29.77 |
| Terumo (TRUMY) | Japan | $25.565B | 36.10 |
| Koninklijke Philips (PHG) | Netherlands | $25.036B | 19.40 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.681B | 15.77 |
| Baxter (BAX) | United States | $17.958B | 12.77 |
| Insulet (PODD) | United States | $12.066B | 53.50 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.266B | 0.00 |
| Demant (WILYY) | Denmark | $10.234B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.385B | 27.43 |
| BellRing Brands (BRBR) | United States | $7.844B | 36.74 |
| Lantheus Holdings (LNTH) | United States | $5.455B | 13.59 |
| Haemonetics (HAE) | United States | $4.945B | 24.47 |
| GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
| Perrigo (PRGO) | Ireland | $4.129B | 12.52 |
| Prestige Consumer Healthcare (PBH) | United States | $3.548B | 16.98 |
| Envista Holdings (NVST) | United States | $3.295B | 13.60 |
| QuidelOrtho (QDEL) | United States | $2.959B | 16.42 |
| Neogen (NEOG) | United States | $2.835B | 27.27 |
| TG Therapeutics (TGTX) | United States | $2.776B | 78.09 |
| Green Thumb Industries (GTBIF) | United States | $2.714B | 53.75 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.690B | 0.00 |
| ICU Medical (ICUI) | United States | $2.565B | 22.63 |
| Agios Pharmaceuticals (AGIO) | United States | $1.938B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.927B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.752B | 51.34 |
| InMode (INMD) | Israel | $1.560B | 8.29 |
| Warby Parker (WRBY) | United States | $1.543B | 0.00 |
| Owens & Minor (OMI) | United States | $1.513B | 13.19 |
| AdaptHealth (AHCO) | United States | $1.306B | 9.73 |
| National Vision Holdings (EYE) | United States | $1.200B | 38.20 |
| AtriCure (ATRC) | United States | $1.042B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.032B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.983B | 0.00 |
| Evolus (EOLS) | United States | $0.799B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.738B | 15.70 |
| Cresco Labs (CRLBF) | United States | $0.698B | 0.00 |
| Quanterix (QTRX) | United States | $0.644B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.631B | 14.83 |
| PetIQ (PETQ) | United States | $0.576B | 18.82 |
| Valneva SE (VALN) | France | $0.558B | 0.00 |
| Jin Medical (ZJYL) | China | $0.522B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.519B | 0.00 |
| Surmodics (SRDX) | United States | $0.471B | 29.46 |
| ZimVie (ZIMV) | United States | $0.455B | 38.79 |
| Biote (BTMD) | United States | $0.443B | 8.50 |
| OraSure Technologies (OSUR) | United States | $0.403B | 12.98 |
| Aurora Cannabis (ACB) | Canada | $0.382B | 0.00 |
| Cerus (CERS) | United States | $0.377B | 0.00 |
| Zynex (ZYXI) | United States | $0.345B | 47.22 |
| MacroGenics (MGNX) | United States | $0.279B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.272B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.260B | 25.77 |
| Sanara MedTech (SMTI) | United States | $0.258B | 0.00 |
| Omeros (OMER) | United States | $0.243B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.242B | 15.22 |
| Veru (VERU) | United States | $0.215B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.197B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.190B | 0.00 |
| High Tide (HITI) | Canada | $0.182B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.172B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.164B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.152B | 73.06 |
| InterCure (INCR) | Israel | $0.148B | 24.96 |
| FitLife Brands (FTLF) | United States | $0.136B | 19.36 |
| Jushi Holdings (JUSHF) | United States | $0.136B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.114B | 0.00 |
| Fonar (FONR) | United States | $0.104B | 8.94 |
| Allurion Technologies (ALUR) | United States | $0.101B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.100B | 0.00 |
| MariMed (MRMD) | United States | $0.096B | 0.00 |
| Brainsway (BWAY) | Israel | $0.091B | 0.00 |
| Chimerix (CMRX) | United States | $0.090B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.078B | 0.00 |
| Safety Shot (SHOT) | United States | $0.067B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.061B | 3.96 |
| Rockwell Medical (RMTI) | United States | $0.050B | 0.00 |
| Apyx Medical (APYX) | United States | $0.049B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.045B | 0.00 |
| ImmuCell (ICCC) | United States | $0.043B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 15.08 |
| Bright Green (BGXX) | United States | $0.041B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| Exagen (XGN) | United States | $0.031B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.019B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.015B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.014B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |